Single center observational study of Nusinersen in adult patients with spinal muscular atrophy
Latest Information Update: 24 Jul 2020
Price :
$35 *
At a glance
- Drugs Nusinersen (Primary)
- Indications Spinal muscular atrophy
- Focus Therapeutic Use
- 24 Jul 2020 New trial record
- 14 Jul 2020 Results published in the Neurology